Fabrice Bailly
Bailly, Fabrice
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 214367271 (Personal)
Permalink: http://viaf.org/viaf/214367271
Preferred Forms
-
100 1 _
‡a
Bailly, Fabrice
-
100 0 _
‡a
Fabrice Bailly
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4. |
|
| 4-Mercaptoimidazoles derived from the naturally occurring antioxidant ovothiols 2. Computational and experimental approach of the radical scavenging mechanism |
|
| Anti-HIV activities of natural antioxidant caffeic acid derivatives: toward an antiviral supplementation diet. |
|
| Antioxidant properties of 3-hydroxycoumarin derivatives |
|
| Antiproliferative and apoptotic effects of the oxidative dimerization product of methyl caffeate on human breast cancer cells. |
|
| Design, synthesis and evaluation of YAP-TEAD complex inhibitors as new anticancer drugs. |
|
| Design, synthesis and glutathione peroxidase-like properties of ovothiol-derived diselenides. |
|
| Development of a series of 3-hydroxyquinolin-2 |
|
| Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids. |
|
| Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles. |
|
| Jeux en Basic-printer : Hector |
|
| Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function |
|
| Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway |
|
| Molecular orbital theory applied to the study of nonsteroidal anti-inflammatory drug efficiency |
|
| Le motif de reconnaissance spécifique de l'ADN, SPKK et son utilisation pour l'élaboration d'hybrides peptide-intercalant |
|
| New 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase--discovery of a new polyhydroxylated antiviral agent |
|
| Non-Photoinduced Biological Properties of Verteporfin. |
|
| Potent mammalian cerebroprotection and neuronal cell death inhibition are afforded by a synthetic antioxidant analogue of marine invertebrate cell protectant ovothiols |
|
| The preclinical discovery and development of dolutegravir for the treatment of HIV. |
|
| Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents. |
|
| Spectroscopic studies of diketoacids-metal interactions. A probing tool for the pharmacophoric intermetallic distance in the HIV-1 integrase active site |
|
| The SPKK motif, a specific nucleic acid-binding unit and its implication for the design of peptide-intercalator hybrid molecules. |
|
| Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions. |
|
| Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones. |
|
| Targeting Transcriptional Enhanced Associate Domains (TEADs). |
|
| The total synthesis of fukiic acid, an HIV-1 integrase inhibitor. |
|
| Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface. |
|
